Location History:
- Capelle, NL (1998)
- Rotterdam, NL (1994 - 2012)
Company Filing History:
Years Active: 1994-2012
Title: The Innovative Contributions of Eric Paul Krenning
Introduction
Eric Paul Krenning is a notable inventor based in Rotterdam, Netherlands. He has made significant contributions to the field of pharmaceuticals, particularly in the development of solutions that aim to protect renal function. With a total of six patents to his name, Krenning's work reflects a commitment to advancing medical science.
Latest Patents
Krenning's latest patents include a groundbreaking invention that combines an amino acid solution with a gelatin derivative to inhibit renal uptake of potentially harmful substances. This invention is crucial for protecting the kidneys in living beings. Another notable patent involves compounds that have a binding affinity for both the αvβ3 receptor and a (neuro)peptide receptor, specifically the somatostatin receptor. This compound features a first peptide part that includes the amino acid sequence Arg-Gly-Asp, coupled with a second peptide part, which is a (neuro)peptide.
Career Highlights
Throughout his career, Krenning has worked with prominent companies such as Novartis AG and Biosynthema Inc. His experience in these organizations has allowed him to refine his skills and contribute to significant advancements in pharmaceutical research.
Collaborations
Krenning has collaborated with esteemed colleagues, including Steven W. Lamberts and Rainer Albert. These partnerships have fostered an environment of innovation and have led to the development of impactful inventions.
Conclusion
Eric Paul Krenning's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his role as a significant inventor. His work continues to influence the medical community and improve patient outcomes.